Lifecore Biomedical Inc. Appoints KPMG as New Auditor Amid Internal Control Weakness Concerns
Lifecore Biomedical Inc. has announced a change in its independent registered public accounting firm. The company's Audit Committee has appointed KPMG LLP as the new independent auditor for the transition period beginning May 26, 2025, and ending December 31, 2025. This decision follows the conclusion of a review and evaluation process. The company had previously identified weaknesses in its internal control over financial reporting and discussed these with its former auditor, BDO. However, there were no disagreements or reportable events between Lifecore and BDO during the fiscal years ended May 26, 2024, and May 25, 2025. KPMG was not consulted on any accounting principles or specific transactions during this time.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lifecore Biomedical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001005286-25-000118), on August 18, 2025, and is solely responsible for the information contained therein.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。